MYC Binding Near Transcriptional End Sites Regulates Basal Gene Expression, Read‐Through Transcription, and Intragenic Contacts
Source abstract
Abstract
Abstract The MYC oncoprotein regulates numerous genes involved in processes such as cell cycle control and mitochondrial and ribosomal structure and function. This requires heterodimerization with its partner, MAX, and binding to specific promoter and enhancer elements. Here, it is shown that MYC and MAX also bind near transcriptional end sites (TESs) of over one‐sixth of all annotated genes. These interactions are dose‐dependent, evolutionarily conserved, stabilize the normally short‐lived MYC protein and regulate expression both in concert with and independent of MYC's binding elsewhere. MYC's TES‐associated binding, occurring in coordination with other transcription factors, alters the chromatin landscape, increases nuclease susceptibility and alters transcriptional read‐through, particularly in response to certain stresses. MYC‐bound TESs can directly contact promoters and appear to fine‐tune gene expression in response to both physiologic and pathologic stimuli. Collectively, these findings support a previously unrecognized role for MYC in regulating transcription and its read‐through via direct intragenic contacts between TESs and promoters.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Genomics and Chromatin Dynamics · DNA Repair Mechanisms · RNA Research and Splicing
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Division of Hematology/Oncology UPMC Children's Hospital of Pittsburgh Pittsburgh PA 15201 USA
Department of Colorectal Surgery The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui 230001 China
The Department of Microbiology and Molecular Genetics UPMC The Hillman Cancer Center of UPMC The Pittsburgh Liver Research Center, UPMC Pittsburgh PA 15224 USA
Funding
National Science Foundation · Hyundai Hope On Wheels · Rally Foundation · National Institutes of Health
References (74)
Show source-provided references
1. 10.1101/cshperspect.a01423310.1101/cshperspect.a014233 ↗
2. 10.3390/cells1124408710.3390/cells11244087 ↗
3. 10.1016/j.jcmgh.2022.02.01810.1016/j.jcmgh.2022.02.018 ↗
4. 10.3390/cells1124397410.3390/cells11243974 ↗
5. 10.3390/ijms2207345810.3390/ijms22073458 ↗
6. 10.1016/j.molcel.2018.09.03110.1016/j.molcel.2018.09.031 ↗
7. 10.1016/j.cell.2010.03.03010.1016/j.cell.2010.03.030 ↗
8. 10.1016/j.bbagrm.2014.05.01610.1016/j.bbagrm.2014.05.016 ↗
9. 10.3390/cells1104074710.3390/cells11040747 ↗
10. 10.1101/gad.7.4.67110.1101/gad.7.4.671 ↗
11. 10.1016/S1097-2765(00)80367-610.1016/S1097-2765(00)80367-6 ↗
12. 10.1074/jbc.M117.78205210.1074/jbc.M117.782052 ↗
13. 10.1016/j.celrep.2023.11283010.1016/j.celrep.2023.112830 ↗
14. 10.1016/S0014-4827(02)00020-410.1016/S0014-4827(02)00020-4 ↗
15. 10.1177/194760191037901210.1177/1947601910379012 ↗
16. 10.1016/j.ceb.2022.01.00310.1016/j.ceb.2022.01.003 ↗
17. 10.1101/gr.276313.12110.1101/gr.276313.121 ↗
18. 10.1126/science.110513610.1126/science.1105136 ↗
19. 10.1126/sciadv.abh363510.1126/sciadv.abh3635 ↗
20. 10.1093/nar/gks119310.1093/nar/gks1193 ↗
21. 10.1158/0008-5472.CAN-20-295910.1158/0008-5472.CAN-20-2959 ↗
22. 10.1101/cshperspect.a01436510.1101/cshperspect.a014365 ↗
23. 10.1016/j.gdata.2014.11.01010.1016/j.gdata.2014.11.010 ↗
24. 10.1038/nature1353710.1038/nature13537 ↗
25. 10.1083/jcb.20070417310.1083/jcb.200704173 ↗
26. 10.3390/genes806015110.3390/genes8060151 ↗
27. 10.1186/s13073-016-0345-510.1186/s13073-016-0345-5 ↗
28. 10.1073/pnas.171112011410.1073/pnas.1711120114 ↗
29. 10.1080/15476286.2016.114968010.1080/15476286.2016.1149680 ↗
30. 10.1007/s10555-023-10103-410.1007/s10555-023-10103-4 ↗
31. 10.1016/j.molcel.2015.02.01410.1016/j.molcel.2015.02.014 ↗
32. 10.1016/j.molcel.2022.12.03210.1016/j.molcel.2022.12.032 ↗
33. 10.1016/j.cell.2006.12.04810.1016/j.cell.2006.12.048 ↗
34. 10.1186/s13059-021-02322-110.1186/s13059-021-02322-1 ↗
35. 10.1186/s13072-023-00502-w10.1186/s13072-023-00502-w ↗
36. 10.1016/j.cell.2016.10.02410.1016/j.cell.2016.10.024 ↗
37. 10.3389/fphar.2021.74783710.3389/fphar.2021.747837 ↗
38. 10.1074/jbc.RA118.00409910.1074/jbc.RA118.004099 ↗
39. 10.1093/nar/gkp33510.1093/nar/gkp335 ↗
40. 10.1016/j.gde.2020.02.02110.1016/j.gde.2020.02.021 ↗
41. 10.1371/journal.pone.018014710.1371/journal.pone.0180147 ↗
42. 10.1016/j.cell.2017.09.02610.1016/j.cell.2017.09.026 ↗
43. 10.1093/nar/gkz59710.1093/nar/gkz597 ↗
44. 10.1016/j.advenzreg.2010.10.00110.1016/j.advenzreg.2010.10.001 ↗
45. 10.1101/gad.179804.11110.1101/gad.179804.111 ↗
46. 10.1186/1471-2164-15-S12-S1110.1186/1471-2164-15-S12-S11 ↗
47. 10.3389/fgene.2022.108108810.3389/fgene.2022.1081088 ↗
48. 10.1016/j.jbc.2022.10211710.1016/j.jbc.2022.102117 ↗
49. Curran T. · Cancer Surv. · 1985 · 4 · 655
50. 10.1371/journal.pone.018270510.1371/journal.pone.0182705 ↗
51. 10.1038/s41580-021-00349-710.1038/s41580-021-00349-7 ↗
52. 10.1016/j.cell.2014.02.00910.1016/j.cell.2014.02.009 ↗
53. 10.1016/j.cell.2018.01.02910.1016/j.cell.2018.01.029 ↗
54. 10.1038/nrg320710.1038/nrg3207 ↗
55. 10.18632/oncotarget.432710.18632/oncotarget.4327 ↗
56. 10.1038/sj.onc.120460610.1038/sj.onc.1204606 ↗
57. 10.1016/j.bbagrm.2014.03.00510.1016/j.bbagrm.2014.03.005 ↗
58. 10.1074/jbc.M31072220010.1074/jbc.M310722200 ↗
59. 10.1186/s12943-018-0857-210.1186/s12943-018-0857-2 ↗
60. 10.1098/rsob.21022010.1098/rsob.210220 ↗
61. 10.1128/MCB.24.10.4092-4103.200410.1128/MCB.24.10.4092-4103.2004 ↗
62. 10.1093/hmg/ddy16710.1093/hmg/ddy167 ↗
63. 10.7554/eLife.0921410.7554/eLife.09214 ↗
64. 10.1016/S0092-8674(02)01284-910.1016/S0092-8674(02)01284-9 ↗
65. 10.1101/gr.135350.11110.1101/gr.135350.111 ↗
66. 10.21203/rs.3.rs‐3111932/v110.21203/rs.3.rs‐3111932/v1 ↗
67. 10.1038/s41587-020-0439-x10.1038/s41587-020-0439-x ↗
68. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
69. 10.1186/s12967-021-02936-w10.1186/s12967-021-02936-w ↗
70. Wu T. · Innovation · 2021 · 2
71. 10.1093/nar/gkab99610.1093/nar/gkab996 ↗
72. 10.1186/s12864-018-4983-410.1186/s12864-018-4983-4 ↗
73. 10.1016/j.jcmgh.2021.02.00410.1016/j.jcmgh.2021.02.004 ↗
74. 10.1369/002215541347686810.1369/0022155413476868 ↗